Larvol Delta - Conteltinib-CT707-in-patients-with-advanced-ALKpositive-nonsmall-cell-lung-cancer-a-multicenter-openlabel-firstinhuman-phase-1-study

Xalkori (crizotinib) - Pfizer

conteltinib (SY-707) - Centaurus Biopharma, Shouyao Holdings

http://www.ncbi.nlm.nih.gov/pubmed/36424628

Nov 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next